---
title: "West Pharmaceutical Services, Inc. (WST.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WST.US.md"
symbol: "WST.US"
name: "West Pharmaceutical Services, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T19:14:14.675Z"
locales:
  - [en](https://longbridge.com/en/quote/WST.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WST.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WST.US.md)
---

# West Pharmaceutical Services, Inc. (WST.US)

## Company Overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.westpharma.com](https://www.westpharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: B (0.28)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.23% |  |
| Net Profit YoY | 16.16% |  |
| P/B Ratio | 7.19 |  |
| Dividend Ratio | 0.29% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 21505834393.95 |  |
| Revenue | 3221000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.13% | A |
| Profit Margin | 16.85% | A |
| Gross Margin | 35.08% | C |
| Revenue YoY | 11.23% | B |
| Net Profit YoY | 16.16% | C |
| Total Assets YoY | 13.59% | B |
| Net Assets YoY | 11.45% | B |
| Cash Flow Margin | 131.80% | B |
| OCF YoY | 11.23% | B |
| Turnover | 0.83 | B |
| Gearing Ratio | 27.24% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - West Pharmaceutical Services, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.23%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "16.16%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "7.19",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.29%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "21505834393.95",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3221000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.13%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "16.85%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "35.08%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "11.23%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "16.16%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.59%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "11.45%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "131.80%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.23%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.83",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "27.24%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 39.63 | 15/59 | 40.11 | 37.20 | 34.63 |
| PB | 7.19 | 47/59 | 6.53 | 6.08 | 5.69 |
| PS (TTM) | 6.68 | 47/59 | 6.57 | 6.06 | 5.60 |
| Dividend Yield | 0.29% | 11/59 | 0.36% | 0.34% | 0.31% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **15**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 10 | 67% |
| Overweight | 2 | 13% |
| Hold | 3 | 20% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 305.23 |
| Highest Target | 400.00 |
| Lowest Target | 310.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/WST.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/WST.US/norm.md)
- [Related News](https://longbridge.com/en/quote/WST.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/WST.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**